Cryoport, Inc.
Cryoport, Inc. (CYRX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CYRX · as of Mar 31, 2025
Ownership Breakdown
159
Institutional Holders
▼ 7 vs Q4
$280.51M
Total Inst. Value
▼ $87.66M vs Q4
50.40M
Shares Outstanding
freeFloat 80.77%
46.13M
13F Shares Held
▼ 1.19M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CYRX largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CADIAN CAPITAL MANAGEMENT, LP pharmaceutical preparations | 4.98M | 9.97% | 9.97% | $30.29B | May 15, 2025 | ▲ 55.0K |
MORGAN STANLEY pharmaceutical preparations | 4.63M | 9.27% | 9.27% | $28.16B | May 15, 2025 | ▼ 28.8K |
BROWN CAPITAL MANAGEMENT LLC pharmaceutical preparations | 4.05M | 8.12% | 8.12% | $24.65B | May 15, 2025 | ▼ 405.2K |
BLACKROCK, INC. pharmaceutical preparations | 3.94M | 7.88% | 7.88% | $23.93B | May 2, 2025 | ▲ 585.6K |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 3.36M | 6.73% | 6.73% | $20.44B | May 15, 2025 | ▼ 778.1K |
VANGUARD GROUP INC pharmaceutical preparations | 2.75M | 5.50% | 5.50% | $16.69B | May 9, 2025 | ▲ 13.2K |
FRED ALGER MANAGEMENT, LLC pharmaceutical preparations | 2.53M | 5.07% | 5.07% | $15.40B | May 16, 2025 | ▼ 34.6K |
THEMATICS ASSET MANAGEMENT pharmaceutical preparations | 1.70M | 3.40% | 3.40% | $10.32B | May 14, 2025 | ▼ 7.1K |
DEUTSCHE BANK AG\ pharmaceutical preparations | 1.39M | 2.79% | 2.79% | $8.47B | May 9, 2025 | ▼ 4.7K |
NEW YORK STATE COMMON RETIREMENT FUND pharmaceutical preparations | 1.15M | 2.29% | 2.29% | $6.96B | Oct 8, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
21
Increased
+2.45M shares2
New Positions
first time holders22
Decreased
−2.88M shares0
Sold Out
fully exitedNet shares change (top 50)
433.7K
+2.45M / −2.88M
Net new holders
+1
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CYRX insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
2
Buy transactions
2
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
STEFANOVICH ROBERT Chief Financial Officer | Mar 23, 2026 | Sale | 1,094 | $8.18 | $8.9K | 279.3K | Form 4 ↗ |
SHELTON JERRELL President, CEO | Mar 23, 2026 | Sale | 2,894 | $8.18 | $23.7K | 1.05M | Form 4 ↗ |
Sawicki Mark W Chief Scientific Officer | Mar 23, 2026 | Sale | 1,341 | $8.18 | $11.0K | 102.4K | Form 4 ↗ |
ZECCHINI EDWARD J See Remarks | Mar 14, 2026 | Award | 21,322 | — | — | 111.7K | Form 4 ↗ |
ZECCHINI EDWARD J See Remarks | Mar 16, 2026 | Sale | 2,014 | $8.00 | $16.1K | 109.7K | Form 4 ↗ |
ZECCHINI EDWARD J See Remarks | Mar 14, 2026 | Award | 63,965 | $8.60 | $550.1K | 64.0K | Form 4 ↗ |
SHELTON JERRELL President, CEO | Mar 16, 2026 | Sale | 7,918 | $8.00 | $63.3K | 1.05M | Form 4 ↗ |
SHELTON JERRELL President, CEO | Mar 14, 2026 | Award | 492,901 | $8.60 | $4.24M | 492.9K | Form 4 ↗ |
Sawicki Mark W Chief Scientific Officer | Mar 14, 2026 | Award | 22,845 | — | — | 106.9K | Form 4 ↗ |
Sawicki Mark W Chief Scientific Officer | Mar 16, 2026 | Sale | 3,235 | $8.00 | $25.9K | 103.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Cryoport, Inc. (CYRX) is primarily owned by institutional investors, who hold approximately 91.5% of total shares outstanding. Company insiders own approximately 19.23%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Cryoport, Inc. is CADIAN CAPITAL MANAGEMENT, LP, holding approximately 4.98 million shares — equal to 9.97% of outstanding shares — as of March 31, 2025.
A total of 159 institutional investors currently hold CYRX stock, with a combined institutional value of approximately $280,513,643 as of the most recent 13F filing period.
Frequently asked questions
CYRX ownershipCryoport, Inc. (CYRX) is primarily owned by institutional investors, who hold approximately 91.5% of shares. The largest shareholder is CADIAN CAPITAL MANAGEMENT, LP with a 9.97% stake. Company insiders hold 19.23%. Data sourced from SEC Form 13F as of March 31, 2025.